JEWISH KING JESUS IS COMING AT THE RAPTURE FOR US IN THE CLOUDS-DON'T MISS IT FOR THE WORLD.THE BIBLE TAKEN LITERALLY- WHEN THE PLAIN SENSE MAKES GOOD SENSE-SEEK NO OTHER SENSE-LEST YOU END UP IN NONSENSE.GET SAVED NOW- CALL ON JESUS TODAY.THE ONLY SAVIOR OF THE WHOLE EARTH - NO OTHER.
1 COR 15:23-JESUS THE FIRST FRUITS-CHRISTIANS RAPTURED TO JESUS-FIRST FRUITS OF THE SPIRIT-23 But every man in his own order: Christ the firstfruits; afterward they that are Christ’s at his coming.ROMANS 8:23 And not only they, but ourselves also, which have the firstfruits of the Spirit, even we ourselves groan within ourselves, waiting for the adoption, to wit, the redemption of our body.(THE PRE-TRIB RAPTURE)
THE NEXT KILLER VACCINE OF RSV IS GOING INTO PEOPLES ARMS.ESPECIALLY PREGNANT WOMEN.AS WE SPEAK.
DISEASES-ANIMAL TO HUMAN ( 500 million Dead )
REVELATION 6:7-8
7 And when he had opened the fourth seal, I heard the voice of the fourth beast say, Come and see.
8
And I looked, and behold a pale horse:(CHLORES GREEN) and his name that
sat on him was Death, and Hell followed with him. And power was given
unto them over the fourth part of the earth,(2 billion) of (8 billion)
to kill with sword,(WEAPONS)(500 million) and with hunger,(FAMINE)(500
million) and with death,(INCURABLE DISEASES)(500 million) and with the
beasts of the earth.(ANIMAL TO HUMAN DISEASE)(500 million).
DRUG PUSHERS AND ADDICTS
1 PET 5:8
8
Be sober,(NOT DRUGED UP OR ALCOHOLICED) be vigilant; because your
adversary the devil, as a roaring lion, walketh about, seeking whom he
may devour:
REVELATION 18:23
23 And the light of a candle
shall shine no more at all in thee; and the voice of the bridegroom and
of the bride shall be heard no more at all in thee: for thy merchants
were the great men of the earth; for by thy sorceries (DRUGS) were all
nations deceived.
REVELATION 9:21 (RAGE OF THE LAST DAYS AGE SATAN WORSHIP AND DRUG SELLING AND JUNKIES)(THEY REFUSE TO REPENT OF THESE SINS)
21
Neither repented they of their murders,(KILLING) nor of their sorceries
(DRUG ADDICTS AND DRUG PUSHERS), nor of their fornication,(SEX OUTSIDE
MARRIAGE OR PROSTITUTION FOR MONEY) nor of their thefts.(STEALING)
WELL
HERE AT THE OLD AGE HOME I'M IN. I WAS JUST ASKED IF I WANTED TO
CONSENT TO TAKING RSV VACCINE SHOTS YESTERDAY. I SAID NO THANKS. AND THE
NURSE THEN CARRIED ONTO THE NEXT ROOM.I DO SAY THIS SAYING TO SOME OF
THE NURSES. WELL IF I'M GOING TO DIE OF A HEART ATTACK. ITS GOING TO BE
BECAUSE I'M TO FAT. NOT BECAUSE OF ANY VACCINE SHOT. YES THE NEW AND
IMPROVED KILLER RSV VACCINE IS READY TO BE SHOT IN YOUR ARM. BE A GOOD
LITTLE SLAVE AND TAKE YOUR SHOT SAYS DADDYS LITTLE BOY JUSTIN.AND TAM AT
HEALTH CANADA.
Contact Us-Health Canada Approves Pfizer’s Bivalent Respiratory Syncytial Virus (RSV) Vaccine for Older Adults and Infants Through Maternal Immunization-04/01/2024
Health Canada’s approval of ABRYSVO helps to address the urgent need to minimize the spread of RSV infections – a disease with flu-like symptoms that can result in respiratory distress1,2,3, and lead to serious infection such as bronchitis or pneumonia, requiring hospital treatment4-ABRYSVO is the only RSV vaccine authorized in Canada for maternal immunization-Kirkland, QC, January 4, 2023 - Pfizer Canada ULC announces the Health Canada approval of ABRYSVOTM, its bivalent Respiratory Syncytial Virus (RSV) vaccine. The vaccine is indicated for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older by active immunization, and the prevention of lower respiratory tract disease and severe lower respiratory tract disease caused by RSV in infants from birth through 6 months of age by active immunization of pregnant individuals.RSV is a common respiratory virus that causes mild disease with cold-like symptoms. In more vulnerable populations, like adults 60 and over, an RSV infection can be severe, especially among those with underlying respiratory or cardiac conditions5. For infants, RSV infection can result in respiratory distress, especially in those less than six months of age, and those with higher risk factors such as congenital heart or lung disease, or prematurity6,7,8.“RSV is a virus that spreads easily and is very difficult to completely avoid,” said Laura Tamblyn Watts, founder and CEO of CanAge. “Older adults living in congregate settings or long-term care, which is over 500,000 Canadians9, have a higher risk of becoming infected with RSV10. It’s important for all of us to be mindful of RSV prevention to help protect our loved ones and more vulnerable populations.““Today’s announcement means Canada has a new option to help protect those most at risk from the severity of RSV infections,” said Andréa Mueller, Primary Care Portfolio Lead at Pfizer Canada. “For those eligible to receive the vaccine, getting vaccinated means helping to ensure babies are protected from their first breath, and helping older adults continue doing what they love with minimized risk of becoming infected. At Pfizer, we take pride in our decades of experience in vaccines, helping to make a positive contribution to public health and the broader community.” Respiratory viruses, including RSV, increase in the fall and winter months, and the impact of RSV on healthcare resources is significant. RSV infection can result in hospitalization, particularly for infants one year or younger, for whom there is an increased risk11. Older adults also have some of the highest costs associated with the disease12. The approval of Pfizer’s vaccine will help to protect those at both early and later stages in life and will reduce the overall health and economic impact of RSV infection12.“Vaccines are considered to be the most effective tool in public health for preventing illness and can help reduce the stress on our healthcare system and professionals including nurses, doctors, and others on the frontline,” said Dr. Darine El-Chaâr, Maternal Fetal Medicine physician at The Ottawa Hospital. “Vaccines administered through maternal immunization can also help play a critical role in decreasing the gap of vulnerability in the first few months of an infant’s life, as well as helping to protect their mothers, who may be at increased risk of severe disease compared with non-pregnant women13. ” Pfizer Canada is currently assessing the timeline of availability for ABRYSVO and is committed to bringing supply of this vaccine to Canadians as quickly as possible.
About Pfizer Canada (WORLD BIGGEST DRUG (PHARMACIA (DRUG STORE) DEALER.
Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. Our diversified health care portfolio includes some of the world's best known and most prescribed medicines and vaccines. We apply science and our global resources to improve the health and well-being of Canadians at every stage of life. Our commitment is reflected in everything we do, from our disease awareness initiatives to our community partnerships. To learn more about Pfizer Canada, visit pfizer.ca or you can follow us on LinkedIn, Facebook, Twitter or YouTube.For further information:Corporate Affairs Canada-1-866-9PFIZER (1-866-973-4937) corporate.affairs.canada@pfizer.com
References
[1] Centers for Disease Control & Prevention. Respiratory Syncytial Virus Infection (RSV). https://www.cdc.gov/rsv/index.html
[2] Vaccine. 2020 Mar 4; 38(11): 2435–2448. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049900/
[3] Government of Canada. Respiratory syncytial virus (RSV): For health professionals. https://www.canada.ca/en/public-health/services/diseases/respiratory-syncytial-virus-rsv/health-professionals.html
[4] The Lung Association. Respiratory Syncytial Virus (RSV). https://www.lung.ca/lung-health/lung-disease/respiratory-syncytial-virus-rsv
[5] Government of Canada. Respiratory syncytial virus: Canadian Immunization Guide. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/respiratory-syncytial-virus.html
[6] Centers for Disease Control & Prevention. Respiratory Syncytial Virus Infection (RSV). https://www.cdc.gov/rsv/index.html
[7] Vaccine. 2020 Mar 4; 38(11): 2435–2448. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049900/
[8] Government of Canada. Respiratory syncytial virus (RSV): For health professionals. https://www.canada.ca/en/public-health/services/diseases/respiratory-syncytial-virus-rsv/health-professionals.html
[9] Statistics Canada. Impacts of the COVID-19 pandemic in nursing and residential care facilities in Canada. https://www150.statcan.gc.ca/n1/pub/45-28-0001/2021001/article/00025-eng.htm
[10] Health Link BC. Respiratory Syncytial Virus (RSV) Infection. https://www.healthlinkbc.ca/illnesses-conditions/infectious-diseases/respiratory-syncytial-virus-rsv-infection
[11] Wingert A, Pillay J, Moore DL, Guitard S, Vandermeer B, Dyson MP, Sinilaité A, Tunis M, Hartling L. Burden of illness in infants and young children hospitalized for respiratory syncytial virus: A rapid review. Can Commun Dis Rep 2021;47(9):381–96. https://doi.org/10.14745/ccdr.v47i09a05
[12] Rafferty, E., Paulden, M., Buchan, S.A. et al. Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age Groups. PharmacoEconomics. https://link.springer.com/article/10.1007/s40273-022-01142-w#citeas
[13] Esposito et al. RSV Prevention in All Infants: Which Is the Most Preferable Strategy? Front. Immunol. https://www.frontiersin.org/articles/10.3389/fimmu.2022.880368/full
Health Canada approves 1st RSV
vaccine for people 60 and older-Shot expected to be available in
'limited' amounts this year-Jennifer La Grassa · CBC · Posted: Aug 04,
2023 5:29 PM EDT |-Health Canada approves RSV vaccine for people 60 and
older.
Health Canada has approved the first vaccine for
respiratory syncytial virus (RSV) for adults age 60 and over, but it may
only be available in "limited" quantities for this fall's respiratory
virus season.RSV is a common but highly contagious virus that appears
like a common cold for most people. In more vulnerable populations, RSV
can cause bronchiolitis — the inflammation of the small airways in the
lung — or pneumonia, say experts. Health Canada approved manufacturer
GSK's new vaccine called Arexvy on Friday. In an email to CBC News, the
federal health body confirmed that it anticipates a limited supply of
the vaccine will be available for the upcoming RSV season. This news
comes after the U.S. Food and Drug Administration (FDA) gave their
approval for the vaccine in May. "It will be a game changer in
significantly preventing severe illness and death, especially amongst
older Canadians," said Dr. Samir Sinha, the director of geriatrics at
Sinai Health and University Health Network in Toronto. Doctors have been
calling for an RSV vaccine for seniors because although the virus is
common, people who are older are more likely to become severely ill and
need hospitalization. First RSV vaccine approved in U.S. after decades
of attempts-"This has been decades long in the making," Dr. Isaac
Bogoch, an infectious disease specialist with the University Health
Network in Toronto, said of the vaccine's approval. "It's a very tough
virus, it can have negative health impacts. It [can] lead to
hospitalization, intensive care unit stays, even death," Bogoch added.
"And it's wonderful to have a vaccine that … appears to significantly
reduce the risk of severe lower respiratory tract disease." Dr. Samir
Sinha stands outside a hospital, wearing a white lab coat. He's looking
directly into the camera.Dr. Samir Sinha, director of geriatrics at
Sinai Health System and the University Health Network in Toronto, says
he will be recommending the vaccine to all of his elderly patients once
its made available. (Ousama Farag/CBC)-RSV not well-tracked in Canada:
experts-It's unclear how many people 60 and older in Canada are
hospitalized or die from the illness, as experts say it's not properly
tracked.According to Sinha, Canada isn't properly screening for RSV and
the illness itself can be hard to detect — making the exact burden
unclear. But he estimates that it can be similar to the rates of
hospitalizations and death seen with influenza — if not worse as the
virus can spread more rapidly and symptoms may take a few days to
develop.In Canada, 12,200 people are hospitalized and 3,500 die from
influenza annually. Vaccine offers more than 80% protection, says GSK-In
a news release issued Friday, GSK said a randomized clinical trial
showed the vaccine has an 82 per cent efficacy in preventing lower
respiratory tract disease caused by RSV, compared to seniors who got a
placebo.The company said it also showed a 94 per cent efficacy in
preventing the illness in seniors with underlying medical conditions."I
think this vaccine will go a long way based on the results that are
available … the vaccine appeared to be safe and appeared to provide very
significant protection," said Bogoch. THE DOSE-It took 60 years, but
RSV vaccines are just around the corner — and could make a big
difference-He added that if the infection spreads to the lower
respiratory tract, it can make it hard for people to breathe so that
they need "supplemental oxygen." This is when people typically end up in
hospital. Sinha said RSV infections can also "trigger other problems in
the body," like a bacterial or viral pneumonia. "So it's not
necessarily that if you get RSV you're going to die of that infection,
but what you might do is trigger other heart or other lung complications
that then can actually cost you your life potentially," he said.
National guidance for the shot expected in 2024.RSV season in Canada
usually starts in the late fall and lasts until spring. Health Canada
said the vaccine is a single dose injection, but it's unclear whether
people will need to get the vaccine every year or a booster. St.
Joseph's Healthcare Hamilton infectious disease physician Dr. Zain
Chagla said available data suggests that people who get the vaccine will
be protected for up to two years. But beyond that, he said further
research is needed. "Hopefully this [vaccine] gets in before RSV season,
but if an older adult accesses the vaccine afterwards, they still could
get a couple years benefit," he said. In an email to CBC News, Health
Canada said that guidance from the National Advisory Committee on
Immunization (NACI) on the use of the vaccine is expected next year.
Drug to help prevent serious RSV illness in babies approved by Health
Canada-It said that based on consultations with Canadian experts, NACI
has "first prioritized (and is currently developing) advice for RSV
products to protect infants before developing advice for older
adults."It added that it will be up to individual provinces and
territories to decide if they will work Arexvy into their existing RSV
programs — and if so, it will work with them individually. Experts like
Sinha say they also hope the Canadian government considers covering the
cost of the vaccine as that can often be a "barrier to access,"
especially in more vulnerable populations. Sinha said that as soon as
the vaccine is made available, he'll be recommending that all his
patients get the shot. What about kids? Last winter was an especially
bad season of RSV in the country, specifically for young kids. In
addition to seniors, infants are at a higher risk of getting very sick
with RSV. There is no RSV vaccine for children, but there are two kinds
of antibody injections that can be given to high-risk babies to help
prevent serious illness. One of them, palivizumab, has often been given
to babies who were born prematurely – but it needs to be injected about
once a month during RSV season to stay effective. A new antibody drug –
nirsevimab, also known by the brand name Beyfortus – was approved by
Health Canada in April. Nirsevimab only requires one injection to
protect babies during the RSV season. It's not yet known how widely it
will be recommended for babies in Canada this fall. On Thursday, the
Centers for Disease Control and Prevention (CDC) in the U.S. recommended
that babies born just before or during the RSV season, as well as
babies who are less than eight months old before the season starts,
should get the nirsevimab shot. The CDC also recommended that the shot
should be given to some eight to 19-month-old babies who are at higher
risk of getting seriously ill from the virus.
